Evaluation of Leptin Levels among Fibromyalgia Patients before and after Three Months of Treatment, in Comparison with Healthy Controls | Zendy

Jacob N. Ablin | Zendy; Natalia Aronov | Zendy; Ilan Shimon | Zendy; Hannah Kanety | Zendy; Clara Pariente | Zendy; Valerie Aloush | Zendy; Ori Elkayam | Zendy; David Levartovsky | Zendy

Open Access

Evaluation of Leptin Levels among Fibromyalgia Patients before and after Three Months of Treatment, in Comparison with Healthy Controls

Author(s) -

Jacob N. Ablin,

Natalia Aronov,

Ilan Shimon,

Hannah Kanety,

Clara Pariente,

Valerie Aloush,

Ori Elkayam,

David Levartovsky

Publication year - 2012

Publication title -

pain research and management

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.702

H-Index - 56

eISSN - 1918-1523

pISSN - 1203-6765

DOI - 10.1155/2012/350654

Subject(s) - leptin , fibromyalgia , medicine , hormone , pathogenesis , body mass index , endocrinology , anxiety , depression (economics) , physical therapy , obesity , psychiatry , economics , macroeconomics

Leptin, an adipocyte-produced cytokine, interacts with various hormones, including those of the hypothalamic-pituitary-adrenal axis. Fibromyalgia is a syndrome characterized by widespread pain accompanied by tenderness. The pathogenesis involves a disturbance in pain processing and transmission by the central nervous system, leading to a general increase in pain perception.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research